Total Payments
$13,936
2024 Payments
$12,656
Companies
25
Transactions
156
Medicare Patients
356
Medicare Billing
$42,692
Payment Breakdown by Category
Other$9,460 (67.9%)
Food & Beverage$4,247 (30.5%)
Travel$148.74 (1.1%)
Education$79.99 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,460 | 7 | 67.9% |
| Food and Beverage | $4,247 | 144 | 30.5% |
| Travel and Lodging | $148.74 | 4 | 1.1% |
| Education | $79.99 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $10,077 | 19 | $0 (2024) |
| ABBVIE INC. | $598.22 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $356.74 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $345.76 | 16 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $330.76 | 6 | $0 (2024) |
| GENZYME CORPORATION | $324.42 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $285.94 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $256.12 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $230.52 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $180.63 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,656 | 123 | Phathom Pharmaceuticals, Inc. ($10,077) |
| 2023 | $718.54 | 23 | E.R. Squibb & Sons, L.L.C. ($135.00) |
| 2022 | $366.36 | 5 | INTERCEPT PHARMACEUTICALS, INC. ($156.16) |
| 2021 | $141.77 | 3 | AbbVie Inc. ($141.77) |
| 2020 | $52.79 | 2 | Gilead Sciences, Inc. ($32.31) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.14 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 12/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: VIROLOGY | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Gastroenterology | ||||||
| 11/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.91 | General |
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: VIROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: VIROLOGY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $37.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Rare Disease | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 342 | 529 | $203,748 | $40,420 |
| 2022 | 1 | 14 | 14 | $19,446 | $2,272 |
Total Patients
356
Total Services
543
Medicare Billing
$42,692
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 58 | $80,562 | $7,476 | 9.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 27 | 27 | $23,073 | $5,515 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $11,810 | $4,618 | 39.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 23 | 85 | $9,738 | $4,543 | 46.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 48 | 160 | $9,382 | $4,253 | 45.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $7,988 | $2,862 | 35.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 25 | $17,950 | $2,435 | 13.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $4,992 | $2,290 | 45.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 22 | 29 | $4,081 | $1,913 | 46.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $17,201 | $1,864 | 10.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $14,634 | $1,539 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,338 | $1,113 | 47.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $19,446 | $2,272 | 11.7% |
About Dr. Niel Dave, MD
Dr. Niel Dave, MD is a Gastroenterology healthcare provider based in Avondale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1487187761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niel Dave, MD has received a total of $13,936 in payments from pharmaceutical and medical device companies, with $12,656 received in 2024. These payments were reported across 156 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,460).
As a Medicare-enrolled provider, Dave has provided services to 356 Medicare beneficiaries, totaling 543 services with total Medicare billing of $42,692. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Avondale, AZ
- Active Since 04/04/2017
- Last Updated 03/25/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487187761
Products in Payments
- VOQUEZNA (Drug) $10,077
- DUPIXENT (Biological) $505.05
- ZEPOSIA (Drug) $407.65
- ENTYVIO (Biological) $356.74
- OCALIVA (Drug) $330.76
- TREMFYA (Drug) $146.13
- HUMIRA (Biological) $141.77
- STELARA (Biological) $139.81
- TRULANCE (Drug) $130.43
- XIFAXAN (Drug) $125.69
- ESTEEM+ (Device) $114.70
- MAVYRET (Drug) $110.98
- RINVOQ (Biological) $109.57
- SKYRIZI (Biological) $100.73
- OMVOH (Drug) $79.58
- LINZESS (Drug) $65.07
- Talicia (Drug) $64.34
- IQIRVO (Drug) $59.43
- XELJANZ (Drug) $53.33
- IBSRELA (Drug) $52.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.